{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:05:28Z","timestamp":1790942728196,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.rec.2012.12.009","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T13:24:27Z","timestamp":1367673867000},"page":"483-496","source":"Crossref","is-referenced-by-count":14,"title":["Progress in Treatment by Percutaneous Coronary Intervention: The Stent of the Future"],"prefix":"10.1016","volume":"66","author":[{"given":"Takashi","family":"Muramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos V.","family":"Bourantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kharlamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Diletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasim","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill D.","family":"Gogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M.","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2012.12.009_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","article-title":"Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty","volume":"301","author":"Gruntzig","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2012.12.009_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.rec.2012.12.009_bib0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.78.5.1121","article-title":"Emergency stenting for acute occlusion after coronary balloon angioplasty","volume":"78","author":"Sigwart","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2012.12.009_bib0025","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.94.6.1247","article-title":"Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study","volume":"94","author":"Hoffmann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2012.12.009_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2012.12.009_bib0040","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","article-title":"Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis","volume":"27","author":"Nordmann","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2012.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial","volume":"375","author":"Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2012.12.009_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial","volume":"378","author":"Stefanini","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0080","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rec.2012.12.009_bib0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.recesp.2012.01.017","article-title":"Trombosis muy tard\u00eda con nuevos stents farmacoactivos: \u00bfha dejado de ser un asunto relevante?","volume":"65","author":"De la Torre Hernandez","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0090","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0095","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2011.06.027","article-title":"Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial","volume":"58","author":"Byrne","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0100","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0105","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.jacc.2012.08.053","article-title":"TCT-44 LEADERS: 5-year follow-up from a prospective, randomized trial of biolimus A9-eluting stents with a biodegradable polymer vs. sirolimus-eluting stents with a durable polymer- final report of the LEADERS study","volume":"60","author":"Serruys","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"Stefanini","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2012.12.009_bib0115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"59","author":"Meredith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","article-title":"Restenosis: delineating the numerous causes of drug-eluting stent restenosis","volume":"4","author":"Farooq","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0125","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/eurheartj\/ehn253","article-title":"Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis","volume":"29","author":"Mehilli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2012.12.009_bib0130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/hrt.2009.172379","article-title":"Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results","volume":"95","author":"Byrne","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.rec.2012.12.009_bib0135","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/ccd.24375","volume":"81","author":"King","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522","article-title":"Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model","volume":"3","author":"Tada","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0145","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.jacc.2012.08.055","article-title":"TCT-46: Comparison of polymer-free BioFreedom stents with durable polymer Taxus Liber\u00e9 stents: 3-year results from the BioFreedom first-in-man trial","volume":"60","author":"Grube","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcin.2009.02.009","article-title":"1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial","volume":"2","author":"Costa","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0155","article-title":"VESTAsync (MIV Therapeutics) program update","author":"Costa","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"issue":"20S1","key":"10.1016\/j.rec.2012.12.009_bib0160","first-page":"B62","article-title":"TCT-229: First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in man BICARE trial","volume":"58","author":"Yu","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0165","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"Massberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0170","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2011.12.009","article-title":"A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions","volume":"59","author":"Carrie","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0175","article-title":"Cre8 program update","author":"Carrie","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"key":"10.1016\/j.rec.2012.12.009_bib0180","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2005.01.048","article-title":"Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry","volume":"45","author":"Aoki","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0185","article-title":"REMEDEE COMBO program update","author":"Haude","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"key":"10.1016\/j.rec.2012.12.009_bib0190","article-title":"Nanoparticle based stents FOCUSnp program update","author":"Seth","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"issue":"10 Pt 2","key":"10.1016\/j.rec.2012.12.009_bib0195","first-page":"F3","article-title":"Interventional cardiac catheterization at Duke Medical Center","volume":"62","author":"Stack","year":"1988","journal-title":"Am JCardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0200","series-title":"Textbook of interventional cardiology","first-page":"787","article-title":"Biodegradable stents","author":"Zidar","year":"1994"},{"key":"10.1016\/j.rec.2012.12.009_bib0205","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1161\/CIRCULATIONAHA.112.103911","article-title":"The disappearing stent: when plastic replaces metal","volume":"125","author":"Waksman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0210","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"Van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2012.12.009_bib0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","article-title":"Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans","volume":"102","author":"Tamai","year":"2000","journal-title":"Circulation"},{"issue":"Suppl. F","key":"10.1016\/j.rec.2012.12.009_bib0220","doi-asserted-by":"crossref","first-page":"F109","DOI":"10.4244\/EIJV5IFA19","article-title":"Ten-year follow-up of the IGAKI-TAMAI stent. A posthumous tribute to the scientific work of Dr","volume":"5","author":"Onuma","year":"2009","journal-title":"Hideo Tamai EuroIntervention"},{"key":"10.1016\/j.rec.2012.12.009_bib0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/heart.89.6.651","article-title":"Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?","volume":"89","author":"Heublein","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.rec.2012.12.009_bib0230","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ccd.20727","article-title":"Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries","volume":"68","author":"Waksman","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0235","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","article-title":"Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial","volume":"369","author":"Erbel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0240","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4244\/JV4I4A82","article-title":"Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents","volume":"4","author":"Ghimire","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.rec.2012.12.009_bib0245","first-page":"61765","article-title":"Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"12","author":"Haude","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0250","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0255","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0260","doi-asserted-by":"crossref","first-page":"B11","DOI":"10.1016\/j.jacc.2012.08.045","article-title":"TCT-37: Five-year clinical outcomes and non-invasive angiographic imaging results with functional assessment after bioresorbable everolimus-eluting scaffold implantation in patients with de novo coronary artery disease","volume":"60","author":"Onuma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0265","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jacc.2008.08.024","article-title":"Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology","volume":"52","author":"Tanimoto","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0270","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0275","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","article-title":"First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study","volume":"5","author":"Ormiston","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rec.2012.12.009_bib0280","article-title":"Bioabsorbable stent. The Boston Scientific and REVA technology","author":"Grube","year":"2009","journal-title":"EuroPCR"},{"key":"10.1016\/j.rec.2012.12.009_bib0285","article-title":"REVA ReZolve clinical program update","author":"Costa","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"issue":"Suppl. F","key":"10.1016\/j.rec.2012.12.009_bib0290","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4244\/EIJV5IFA13","article-title":"Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview","volume":"5","author":"Yan","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.rec.2012.12.009_bib0295","article-title":"First-in-man results with a myolimus-eluting bioresorbable PLLA-based vascular scaffold","author":"Verheye","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"key":"10.1016\/j.rec.2012.12.009_bib0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ccd.21607","article-title":"Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating","volume":"72","author":"Jabara","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"issue":"Suppl. F","key":"10.1016\/j.rec.2012.12.009_bib0305","doi-asserted-by":"crossref","first-page":"F58","DOI":"10.4244\/EIJV5IFA10","article-title":"Novel fully bioabsorbable salicylate-based sirolimus-eluting stent","volume":"5","author":"Jabara","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.rec.2012.12.009_bib0310","article-title":"The ART stent: design and early first-in-man experiences","author":"Fajadet","year":"2012","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"key":"10.1016\/j.rec.2012.12.009_bib0315","first-page":"301","article-title":"Preliminary evaluation of fully bioabsorbable PLLA sirolimus eluting stents in a porcine model","volume":"19","author":"Shen","year":"2009","journal-title":"Chin J Intervent Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0320","article-title":"Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model","author":"Shen","year":"2011","journal-title":"Transcatheter Cardiovascular Therapeutics"},{"key":"10.1016\/j.rec.2012.12.009_bib0325","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0330","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2012.12.009_bib0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","article-title":"From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?","volume":"33","author":"Serruys","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2012.12.009_bib0340","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4244\/EIJV3I2A51","article-title":"Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents","volume":"3","author":"Ramcharitar","year":"2007","journal-title":"EuroIntervention"},{"key":"10.1016\/j.rec.2012.12.009_bib0345","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2012.12.009_bib0350","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0021-9290(00)00066-X","article-title":"Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution","volume":"33","author":"Wentzel","year":"2000","journal-title":"J Biomech"},{"issue":"Suppl. C","key":"10.1016\/j.rec.2012.12.009_bib0355","first-page":"C27","article-title":"The influence of shear stress on in-stent restenosis and thrombosis","volume":"4","author":"Wentzel","year":"2008","journal-title":"EuroIntervention"}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585713000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585713000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:26:28Z","timestamp":1539671188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585713000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1885585713000364"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2012.12.009","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}